New approach to combat influenza and herpes with bean -based gum

In today’s interconnected world, infectious diseases are a gradual threat, as evidenced by the pandemic of Koronai and H1N1, Sars, Ebola, Zika and H5N1 (bird flu) that had significant global health and economic effects.

But the most common viral diseases also contribute to global health challenges and financial costs. For example, influenza seasonal epidemics occur annually, causing a significant burden on global disease and economic losses exceeding $ 11.2 billion each year only in the United States. Meanwhile, Jirus-1 (HSV-1) of herpes (HSV-1), which spreads mainly through oral contact, infects more than two-thirds of the world population and is the leading cause of infectious blindness in western countries.

Low vaccination rates for influenza viruses and the lack of HSV vaccine emphasize the need for a new approach-one aimed at reducing viral loads in places where transmission occurs. And for viruses such as those, which are more effectively transmitted through the mouth by the nose, it means that it focuses on the oral cavity.

Now, in a study published in Molecular therapyResearchers at the School of Dental Medicine at the University of Pennsylvania and its associates in Finland have done exactly that.

Based on their previous work-now on the clinical trial-appearance that a similar approach was able to reduce Sars-COV-2 in Saliva or SWAB samples from Covid-19, Henry Daniell, Professor WD Miller at the Penn Dental School and his associates, and his associates, Lablab purpureus-Naturally contains an Antiviral Trap (Fril) protein -In eliminate two shingles simple viruses (HSV-1 and HSV-2) and two strains of influenza A (H1N1 and H3N2). The synthesis of chewing gum allowed the effective and consistent release of FRIL in viral infection positions.

They showed that 40 milligrams of one tablet of the two grams of beans were sufficient to reduce viral loads by more than 95%, a decrease similar to those found in the SARS-COV-2 study.

It is important that the researchers have prepared the gum as a clinical quality medicinal product to comply with FDA specifications for medicinal products and found that the gum is safe.

These observations are well enhanced for the evaluation of beans in human clinical trials to minimize virus infection/transmission. ”

Henry Daniell, Professor WD Miller at the Penn’s School of Dentistry

Daniell and his colleagues are now trying to use Lablab bean powder to deal with bird flu, which currently has a significant impact on North America. In the previous three months, 54 million birds have been affected by H5N1 and have reported several human infections in the US and Canada.

Previously, bean dust has been proven by others to effectively neutralize H5N1 and H7N9-two influenza executives who are known to cause bird flu in both humans and birds. Daniell and his colleagues are currently trying to try his use in the flow of birds to help control bird flu in birds.

“Controlling virus transmission is still a major global challenge. A broad antiviral protein (Fril) present in a natural nutrition product (bean powder) to neutralize not only the viruses of human influenza but also the influenza of birds (birds) is a timely innovation.